Chosa Oncology Investor Relations Material
Latest events
Q1 2025
30 May, 2025
Q4 2024
28 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chosa Oncology
Access all reports
Chosa Oncology AB is a Sweden-based biotechnology company focused on the development of innovative cancer therapies. The company specializes in identifying and advancing novel treatment options targeting unmet medical needs in oncology. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
CHOSA
Country
🇸🇪 Sweden